MedPage Today on MSN

FDA's $250K Travel Bill; Q&A With Retsef Levi; Staffers Air Hoeg Concerns

Retsef Levi, PhD, who teaches operations management and healthcare decision-making at MIT and is not a physician, was ...

FDA approves label change for Depo-Provera, adding brain tumor warning

Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with ...

FDA sends warning to major retailers including Target, Walmart amid infant botulism outbreak

The infant botulism outbreak is linked to recalled formula sold online and in stores like Albertsons, Kroger Target, and ...

FDA commissioner on growing public mistrust of government health advice

FDA Commissioner Martin Makary discusses vaccine policy, COVID-era decisions and the erosion of trust in government health ...

FDA says it may relax warning label rule for dietary supplements

Supplements aren’t reviewed for safety and effectiveness, but disclaimers about health benefits are required on products.

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...
Fierce Pharma

Novo gets FDA warning letter at troubled Indiana site formerly owned by Catalent

Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it ...